Photo: Kirsten Boyd Goldberg/Linkedin
Jun 7, 2023, 03:37
Addressing Cisplatin and Carboplatin Shortages: Insights from FDA Oncology Center of Excellence Director
In this open access discussion, Richard Pazdur, Director of the FDA Oncology Center of Excellence, sheds light on the root causes of the cisplatin and carboplatin shortages and proposes potential solutions to alleviate the issue.
https://cancerletter.com/conversation-with-the-cancer-letter/20230530_1/